Early detection represents one of the most promising approaches to reducing the growing
cancer burden. It already has a key role in the management of cervical and breast cancer, and …

Background: Overdiagnosis of clinically insignificant prostate cancer is considered a major
potential drawback of prostate-specific antigen (PSA) screening. Quantitative estimates of the …

Recent developments in such areas of research as geneexpression microarrays, proteomics,
and immunology offer new approaches to cancer screening (1). The surge in research to …

Importance Breast cancer is a leading cause of premature mortality among US women.
Early detection has been shown to be associated with reduced breast cancer morbidity and …

In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began
the process of a complete update of recommendations for early prostate cancer detection. A …

Purpose : The guideline purpose is to provide the urologist with a framework for the early
detection of prostate cancer in asymptomatic average risk men. Materials and Methods : A …

Tumor heterogeneity may reduce the efficacy of molecularly guided systemic therapy for
cancers that have metastasized. To determine whether the genomic alterations in a single …

Objective To quantify the plausible contribution of prostate-specific antigen (PSA) screening
to the nearly 30% decline in the US prostate cancer mortality rate observed during the 1990s…

In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed
among adults and the second leading cause of death from cancer. For this guideline update, …

The American Cancer Society (ACS) recommends that individuals with a cervix initiate
cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) …